Menu

Texas Health Catalyst

Accelerating the translation of research to health products
#txhealthcatalyst

Texas Health Catalyst illustration
.

A program of Dell Medical School in collaboration with the Cockrell School of Engineering, College of Natural Sciences, College of Pharmacy and Office of Technology Commercialization at The University of Texas at Austin. We welcome Seton Healthcare Family as our strategic partner for the 2016-2017 Texas Health Catalyst cycle. 

Texas Health Catalyst aims to:

  • Identify promising translational research that has the potential to become a value-based health product.
  • Provide timely and customized guidance on the research and development pathway from industry and clinical experts.
  • Grant seed funding for exceptional projects that may otherwise not have a source for support.

Benefits to Applicants:

Awardees can receive up to $100K to help advance their research but the benefits of the program extend far beyond the award grant.

  • All applicants receive customized feedback regarding the merits of their research project, potential roadblocks in their clinical translation plan and how to address some of these barriers.
  • During the consultation phase, applicants work closely with experienced industry experts who provide not only specific strategic, regulatory and marketing expertise, but also introductions to potential collaborators, licensing targets and sources of funding.
  • The customized guidance offered at each stage during the program can help hone clinical development strategies, improve market potential and build momentum to help to move these solutions from bench to bedside.  

Request for Proposals 2016-17

For the 2016-17 cycle, Texas Health Catalyst seeks to support product-focused research projects with promising early evidence to improve the value of care under the broad categories of:

Osteoarthritis & Other Musculoskeletal Conditions | Download the RFP >

Examples include (but are not limited to):

  • Prevention and management of osteoarthritis including solutions to reduce the number of total joint replacement surgeries, decrease costs and lower readmission and revision surgery rates
  • Diagnosis and treatment of musculoskeletal conditions including rheumatoid arthritis, osteoporosis and back pain
  • Pain management
  • Infection prevention and control
  • Patient-centered engagement and monitoring
  • Clinical workflow improvements
  • Data analytics for clinical decision support and care coordination
  • Rehabilitation solutions
  • Post-acute care management
  • Other solutions that improve the value of care

Women's Health | Download the RFP >

Examples include (but are not limited to):

  • Improving care before, during and after pregnancy
  • Diagnosis and management of conditions associated with high-risk pregnancies such as diabetes, hypertension, postpartum hemorrhage, and pre-term labor
  • Diagnosis and treatment of gynecological cancers, endometriosis, polycystic ovarian disease, urinary incontinence, and mental health conditions
  • Diagnosis and treatment of urinary tract infections, STIs & HIV, sepsis and other infections (including combating antibiotic resistance)
  • Patient-centered engagement and monitoring
  • Clinical workflow improvements
  • Data analytics for clinical decision support and care co-ordination
  • Other solutions that improve the value of care

See individual RFPs for more details about the focus areas and examples of solutions to be considered. Please contact us with any questions.

 Eligibility

Primary investigators must be:

  • UT Austin faculty members (residents and post-docs can apply as co-PIs with a UT Austin faculty PI)
  • Dell Medical School clinical affiliates
  • Seton Healthcare clinicians (residents can apply as co-PIs with a Seton clinician PI)

Projects will be scored based on the following criteria:

  • Scientific rationale
  • Clinical unmet need
  • Development feasibility
  • Potential for health impact, including commercial attractiveness to ensure path to market
  • Intellectual property status
  • New for the 2016-17 cycle: Ability to improve value of care (i.e. achieve better outcomes without increasing costs or lower costs without diminishing outcomes)

Contact us if you have any questions about eligibility including project fit, scoring criteria, industry partners and other collaborators. There may be opportunities for startups, nonprofits and other organizations to engage with the program if they align with clinical focus areas. 

▲ Collapse

 

 How to Apply

Read through the RFPs (Osteoarthritis & other Musculoskeletal Conditions and Women’s Health) to ensure that your proposed project aligns with our priorities and goals and meets our eligibility criteria.

Download, complete and submit the pre-proposal to TexasHealthCatalyst@austin.utexas.edu before 5 p.m. Friday, June 17, 2016. 

Applicants may submit multiple pre-proposals for unique projects.

▲ Collapse

 

 How It Works

Initial Selection Process
Researchers submit brief pre-proposals for projects that target a specific health need and have the potential to translate research into a value-based therapeutic, diagnostic, device or digital health product. Following a review of pre-proposals, Texas Health Catalyst will invite select applicants to submit full applications.

Industry Guidance & Consulting Awards
Proposals are reviewed by the Texas Health Catalyst Advisory Panel, which includes Austin-area life sciences leaders and experts in fields ranging from product development and venture capital to regulatory issues and patent law. Consulting awardees are paired with members of the Advisory Panel to receive customized guidance on product development feasibility and preclinical steps. 

Financial Awards
Proposals that move past the consulting phase compete to receive awards of up to $100,000.

Award Timeline

Stage 1: Application & Review (June-September) 

  • Pre-proposals submitted (Submission Deadline: June 17, 2016 )
  • Select projects invited to submit full application (Submission Deadline: July 21, 2016)
  • Proposals reviewed by a panel of industry and clinical advisors

Stage 2: Consultation (October-November)

  • Select number of applicants granted consultation awards based on review panel scoring & feedback
  • Projects teams matched with expert industry panel members to address gaps and prepare for final report out 

Stage 3: Final Presentations, Review & Awards (December) 

  • Consulting awardees present their proposals at the report-out event (December 2016)
  • Final decisions on funding awards of up to $100,000 (direct costs)
  • Funding period: January-December 2017

Acknowledgments
Texas Health Catalyst is grateful to the Catalyst program at The University of California, San Francisco for sharing guidance and materials to help launch this program.

▲ Collapse

 

 


Deadline

Remember, pre-proposals are due no later than 5 p.m. Friday, June 17, 2016. Submit a pre-proposal >